The diagnosis of pancreatic neuroendocrine tumours (PanNETs) is increasing owing to
more sensitive detection methods, and this increase is creating challenges for clinical …

In tumor-bearing mice and cancer patients, tumor progression is often associated with
altered hematopoiesis leading to the accumulation of myeloid cells. Extensive studies in …

De novo expression of B7-1 impaired tumorigenicity of TRAMP-C2 mouse prostate
adenocarcinoma (TRAMP-C2/B7), but it did not elicit a protective response against TRAMP-C2 …

Objective Recent studies have found aristaless-related homeobox gene (ARX)/pancreatic
and duodenal homeobox 1 (PDX1), alpha-thalassemia/mental retardation X-linked (ATRX)/…

Background Laparoscopic distal pancreatectomy (LDP) is increasing in popularity thanks to
the benefits that have been recently demonstrated by many authors. The Da Vinci ® Surgical …

Background: Mixed adenoneuroendocrine carcinomas (MANECs) of the gastrointestinal tract
are rare neoplasms characterized by coexisting exocrine and neuroendocrine neoplastic …

Purpose Lu-DOTATATE (Lu-PRRT) is a valid therapeutic option in differentiated pancreatic
neuroendocrine tumors (P-NETs). FDG PET seems to be an important prognostic factor in P-…

The interleukin-6 (IL-6) and the chemokine CCL5 are implicated in the development and
progression of several forms of tumours including that of the prostate. The expression of the …

Objective Evidence is limited regarding outcome of patients with ectopic Cushing's syndrome
(ECS) due to neuroendocrine tumors (NETs). Design We assessed the prognostic factors …

Immunology-based interventions have been proposed as a promising curative chance to
effectively attack postoperative minimal residual disease and distant metastatic localizations of …